vTv Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: vTv Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
vTv Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.51M, a 21.2% decline year-over-year.
vTv Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24M, a 11.6% increase year-over-year.
vTv Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$25.5M, a 13.1% decline from 2022.
vTv Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$22.5M, a 4.05% decline from 2021.
vTv Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$21.7M, a 82.8% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$24M	-$6.51M	-$1.14M	-21.2%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	-$22.9M	-$7.16M	+$845K	+10.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	-$23.7M	-$5.63M	+$1.8M	+24.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$25.5M	-$4.71M	+$1.64M	+25.8%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-13
Q3 2023	-$27.1M	-$5.37M	+$321K	+5.64%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	-$27.5M	-$8M	-$3.97M	-98.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	-$23.5M	-$7.43M	-$946K	-14.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$22.5M	-$6.34M	+$4.77M	+42.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-13
Q3 2022	-$27.3M	-$5.69M	-$4.09M	-255%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$23.2M	-$4.03M	+$643K	+13.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$23.9M	-$6.48M	-$2.2M	-51.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$21.7M	-$11.1M	-$12.9M	-707%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-13
Q3 2021	-$8.72M	-$1.6M	+$1.23M	+43.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	-$9.95M	-$4.67M	-$466K	-11.1%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$9.49M	-$4.28M	+$2.37M	+35.6%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$11.9M	$1.83M	+$8.22M		Oct 1, 2020	Dec 31, 2020	10-K	2023-03-06
Q3 2020	-$20.1M	-$2.83M	+$2.59M	+47.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020	-$22.7M	-$4.2M	+$588K	+12.3%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	-$23.3M	-$6.65M	-$2.36M	-55%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	-$20.9M	-$6.39M	-$6.04M	-1720%	Oct 1, 2019	Dec 31, 2019	10-K	2020-02-21
Q3 2019	-$14.9M	-$5.43M	-$3.94M	-266%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$10.9M	-$4.79M	+$4.07M	+45.9%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-03
Q1 2019	-$15M	-$4.29M	+$4.85M	+53.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$19.8M	-$351K	+$12.4M	+97.3%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-21
Q3 2018	-$32.2M	-$1.48M	+$10.1M	+87.2%	Jul 1, 2018	Sep 30, 2018	10-K	2020-02-21
Q2 2018	-$42.3M	-$8.86M	+$3.76M	+29.8%	Apr 1, 2018	Jun 30, 2018	10-K	2020-02-21
Q1 2018	-$46.1M	-$9.13M	+$4.62M	+33.6%	Jan 1, 2018	Mar 31, 2018	10-K	2020-02-21
Q4 2017	-$50.7M	-$12.8M	+$541K	+4.06%	Oct 1, 2017	Dec 31, 2017	10-K	2019-02-26
Q3 2017	-$51.2M	-$11.5M	+$1.99M	+14.7%	Jul 1, 2017	Sep 30, 2017	10-K	2019-02-26
Q2 2017	-$53.2M	-$12.6M	+$2.02M	+13.8%	Apr 1, 2017	Jun 30, 2017	10-K	2019-02-26
Q1 2017	-$55.2M	-$13.8M	-$214K	-1.58%	Jan 1, 2017	Mar 31, 2017	10-K	2019-02-26
Q4 2016	-$55M	-$13.3M	-$2.22M	-20%	Oct 1, 2016	Dec 31, 2016	10-K	2018-02-27
Q3 2016	-$52.8M	-$13.5M	-$4.09M	-43.3%	Jul 1, 2016	Sep 30, 2016	10-K	2018-02-27
Q2 2016	-$48.7M	-$14.6M	-$6.75M	-85.6%	Apr 1, 2016	Jun 30, 2016	10-K	2018-02-27
Q1 2016	-$42M	-$13.5M	-$3.82M	-39.3%	Jan 1, 2016	Mar 31, 2016	10-K	2018-02-27
Q4 2015	-$38.1M	-$11.1M	-$4.42M	-66.3%	Oct 1, 2015	Dec 31, 2015	10-K	2017-02-24
Q3 2015	-$33.7M	-$9.44M	-$3.92M	-71%	Jul 1, 2015	Sep 30, 2015	10-K	2017-02-24
Q2 2015	-$29.8M	-$7.89M	-$697K	-9.69%	Apr 1, 2015	Jun 30, 2015	10-K	2017-02-24
Q1 2015	-$29.1M	-$9.72M	-$204K	-2.14%	Jan 1, 2015	Mar 31, 2015	10-K	2017-02-24
Q4 2014	-$28.9M	-$6.67M			Oct 1, 2014	Dec 31, 2014	10-K	2016-03-04
Q3 2014		-$5.52M			Jul 1, 2014	Sep 30, 2014	10-K	2016-03-04
Q2 2014		-$7.19M			Apr 1, 2014	Jun 30, 2014	10-K	2016-03-04
Q1 2014		-$9.52M			Jan 1, 2014	Mar 31, 2014	10-K	2016-03-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.